Results 141 to 150 of about 924 (199)

<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2. [PDF]

Antimicrob Agents Chemother
McElheny CL, Butcher EL, Kawai A, Shanks RMQ, Shields RK, Doi Y.   +5 more
europepmc   +1 more source

Carbapenem-resistant <i>Acinetobacter</i> (CRAB) and outpatient antibiotic therapy (OPAT): between a rock and hard place. [PDF]

JAC Antimicrob Resist
White BP, Siegrist EA.
europepmc   +1 more source

Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinants. [PDF]

Antimicrob Agents Chemother
Báez-Barroso G-A, Rodríguez-Coello A, Vázquez-Ucha JC, López-Argüello S, Outeda-García M, González-Pinto L, García-Pose A, Guijarro-Sánchez P, Alonso-García I, Lence E, González-Bello C, Oliver A, Arca-Suárez J, Moya B, Bou G, Beceiro A, Spanish National Acinetobacter spp. 2020 Study Group.   +16 more
europepmc   +1 more source

In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA [PDF]

Bianco, G., Boattini, M.
core   +1 more source

From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem? [PDF]

Curr Opin Infect Dis
Bonazzetti C, Giannella M, Pascale R.
europepmc   +1 more source

Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant Acinetobacter baumannii patient isolates with diverse resistance mechanisms. [PDF]

J Antimicrob Chemother
Halim J, Keane AP, Bouzo J, Aderibigbe T, Chicola JA, Nolan KT, Jonnalagadda K, Tran JX, Carabetta VJ.   +8 more
europepmc   +1 more source

Precision Approaches to Carbapenem-Resistant Infections in the ICU: Integrating Diagnostics, Stewardship, and Novel Therapies. [PDF]

Diagnostics (Basel)
Morena R, Gullì SP, Serapide F, Russo A.   +3 more
europepmc   +1 more source

Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio study. [PDF]

Antimicrob Agents Chemother
Buyukyanbolu E, Argotsinger J, Beck ET, Chamberland RR, Clark AE, Daniels AR, Liesman R, Fisher M, Gialanella P, Hand J, Harrington AT, Humphries RM, Huse H, Hamilton-Seth R, Hankins JD, Kufel WD, Riddell SW, Marino J, Westblade LF, Mochon AB, Narayanan N, Kirn TJ, Pierce VM, Potula R, Tekle T, Simner PJ, Tibbetts RJ, Vu C, Abbo LM, Martinez O, Dumm RE, Nicolau DP, Asempa TE, Acinetobacter baumannii Complex National Biorepository (ACNBio) Study Group.   +33 more
europepmc   +1 more source

Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii Infections

International Journal of Pharmaceutical Investigation
Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy, B J Abhishek, Leena Elizabeth Varghese, S K Bhoomika   +4 more
openaire   +1 more source

Can we escape from top-priority ESKAPE pathogens? [PDF]

Emerg Microbes Infect
Zeng L, Feng Y, Wang M.
europepmc   +1 more source